Fragalysis
Fragalysis is a cloud-based platform developed in collaboration with the University of Oxford and Diamond Light Source that accelerates drug development using chemical compound screening and X-ray crystallography. It allows scientists to analyze thousands of compounds quickly and efficiently, with the data available in a web-based application to support drug discovery.
The project is funded by Janssen, a major pharmaceutical partner and part of Johnson & Johnson, as well as other sponsors, who provide open access to this innovative platform for scientists around the world.
Fragment analysis
Fragalysis team
The team is led by Professor Frank von Delft from the University of Oxford, an expert in protein crystallography and antiviral drug development.
The data curator is Rachael Skyner from Diamond Light Source, who specializes in automated data processing.
Frontend development is provided by Boris Kovář from M2M Solutions.
